When will the coronovirus epidemic end? This is the question that almost everyone in the world would like to answer. It has been more than half a year since the World Health Organization officially declared COVID-19 an epidemic. Those months have been unrealistic for many people. And they are ready to be normal for life.
Billionaire philanthropist and Microsoft Co-founder Bill Gates feels he can have a good idea of when the epidemic will end. And they doubt they might know when things will start to normalize in America
Prediction of bill gates
In an interview with Fox news sunday, Gates told host Chris Wallace that he is “optimistic [the pandemic] Will not go on indefinitely. “So when will he predict it will end? Gates said that” the end of the epidemic, the best case, is probably 2022. ”
This appeal to tired Americans may not sound very good; 2022 still seems like a long way off. And Gates’ reference to being a “best case” probably won’t give many people a warm and fuzzy feeling.
However, the billionaire made more positive predictions. He said that he felt that some coronovirus vaccines would gain approval by early 2021. When this happens, Gates predicts that “America will be back to normal by next summer and we may have activities by the end of the year. Absolutely normal.”
However, there was an important caveat in Gates’ time. He said the key to ending the epidemic is for the US to help developing countries get COVID-19 vaccines. Until coronovirus outbreaks occur worldwide, Gates worries that the epidemic may return to the US
Will that be proved right?
There are good reasons to believe that Gates’ projected timeline for approval of the coronovirus vaccine is on target. Three COVID-19 vaccine candidates are in active late-stage testing; AstraZeneca Still awaiting approval from the Food and Drug Administration to resume its late US study, after the trial was halted due to severe adverse reactions from a participant in a UK clinical trial.
Two drug manufacturers with late-stage COVID-19 vaccine candidates – Pfizer And Moderna – It is expected to report preliminary results in the fourth quarter of 2020. This could pave the way for both companies to obtain the FDA Emergency Use Authority (EUA) by early next year or possibly later this year.
It would be several months after the first coronavirus vaccination to receive EUAS, before most Americans could be vaccinated. However, Gates believes that in the summer of 2021 life in the US may begin to return to normal.
But will the epidemic actually continue until 2022? Probably because, at least in other parts of the world. Whether or not the initial supply of COVID-19 vaccines will go to many wealthier countries that are already locked in supply agreements with leaders in the race for the coronovirus vaccine.
Meanwhile stock to buy
With one more year or more disruption to normal life for Americans, which stocks should investors buy in the meantime? There are two categories that look like smart pics.
First, consider buying shares of companies that are important to fight coronovirus. Abbott Laboratories (NYSE: ABT) Stands out as a great example. The company is a leader in COVID-19 testing, with six trials winning FDA EUAs. Abbott’s Binaxo Cov-19 AG card test, in particular, can be a game-changer: it’s faster, cheaper, and simpler.
These are not the only reasons for preferring the COVID-19 test Abbott, however. The company has several other major growth drivers, notably including its Freestyle Libre 2 continuous glucose monitoring system. Abbott is also a dividend aristocrat, with 48 consecutive years of increased dividends.
Second, examine the stocks of companies that would benefit from the effects of the epidemic in the long run. Adventuress (NASDAQ: AMZN) Ranks as an obvious choice on this front. The outbreak of COVID-19 has resulted in consumers shopping online more than ever before; Amazon, the global leader in e-commerce, has seen a boom in its business.
Amazon’s cloud businesses also continue to enjoy solid momentum. The company is expanding its grocery focus. It wants to reduce shipping costs for its e-commerce business by using drones to deliver packages.
Both Abbott and Amazon are set to perform well due to the prolonged epidemic. And both are good for rewarding investors in the years after the epidemic is over.